| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 876,402 | 611,607 | 476,748 | 328,572 |
| Depreciation and amortization | 6,765 | 7,018 | 5,975 | 6,530 |
| Stock-based compensation | 201,592 | 196,405 | 172,318 | 159,971 |
| Unrealized and realized (gain) loss from marketable securities, net | NaN | -16,223 | -5,457 | 11,140 |
| Noncash consideration | NaN | -5,191 | -7,612 | -7,128 |
| Other operating activities | -53,959 | -203 | -10,700 | 23,002 |
| Accounts receivable, net | 360,973 | 27,452 | 259,476 | 28,542 |
| Prepaid expenses and other assets | -49,062 | -1,636 | -57,650 | 48,037 |
| Accounts payable and accrued liabilities | 80,788 | -85,923 | 42,380 | 25,807 |
| Contract liabilities | 112,386 | 78,534 | 39,488 | 101,906 |
| Other liabilities | -12,898 | -15,359 | -14,564 | -11,690 |
| Net cash provided by operating activities | 899,165 | 777,295 | 507,664 | 539,251 |
| Purchases of property and equipment | 7,401 | 13,272 | 6,792 | 7,634 |
| Purchases of marketable securities | 810,856 | 1,610,547 | 3,515,282 | 871,511 |
| Proceeds from sales and redemption of marketable securities | 791,533 | 665,988 | 3,707,565 | 302,135 |
| Purchases of privately-held securities | NaN | 0 | 2,924 | 70,000 |
| Other investing activities | 0 | 0 | -29,000 | NaN |
| Net cash used in investing activities | -26,724 | -957,831 | 181,567 | -617,010 |
| Proceeds from the exercise of common stock options | 4,899 | 8,268 | 25,638 | 28,617 |
| Repurchases of common stock | NaN | 19,196 | 19,195 | 18,596 |
| Taxes paid related to net share settlement of equity awards | NaN | 0 | 0 | 3,544 |
| Other financing activities | -1,502 | 30 | -8 | -27 |
| Net cash provided by (used in) financing activities | 3,397 | -10,898 | 6,435 | 6,450 |
| Effect of foreign exchange on cash, cash equivalents, and restricted cash | -2,404 | -1,967 | -2,074 | 7,538 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 873,434 | -193,401 | 693,592 | -63,771 |
| Cash, cash equivalents, and restricted cash - beginning of period | 1,451,425 | 1,644,826 | 951,234 | 1,015,005 |
| Cash, cash equivalents, and restricted cash - end of period | 2,324,859 | 1,451,425 | 1,644,826 | 951,234 |
Palantir Technologies Inc. (PLTR)
Palantir Technologies Inc. (PLTR)